Akari Therapeutics Investor Relations Material
Latest events
Q2 2025
13 Aug, 2025
Company Presentation
13 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Akari Therapeutics PLC
Access all reports
Akari Therapeutics PLC is a clinical-stage biopharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases. The company’s research primarily targets conditions involving the complement and leukotriene pathways, which play key roles in immune system regulation. Akari Therapeutics is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Key slides for Akari Therapeutics PLC
Company Presentation
Akari Therapeutics PLC
Corporate Presentation
Akari Therapeutics PLC
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
AKTX
Country
🇺🇸 United States